In addition, ASOs and small interfering RNA (siRNA) were confirmed as efficient in pre-clinical models of ALS with C9ORF72 and FUS mutations, and various clinical trials using this approach are ongoing [110,111,114]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.